Main Street Investment Advisors LLC Amgen Inc Transaction History

Main Street Investment Advisors LLC

$702 Million
Q2 2025

A detailed history of Main Street Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Main Street Investment Advisors LLC holds 1,639 shares of AMGN stock, worth $484,832. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,639

Previous 1,589 3.15%

Holding current value

$484,832

Previous $495,000 7.68%

% of portfolio

0.07%

Previous 0.07%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$262.28 - $309.85 $13,113 - $15,492	50 Added 3.15%	1,639 $457,000
Q1 2025 Apr 30, 2025	SELL	$258.59 - $327.36 $87,662 - $110,975	-339 Reduced 17.58%	1,589 $495,000
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $2,846 - $3,611	-11 Reduced 0.57%	1,928 $502,000
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $337,224 - $367,744	-1,090 Reduced 35.99%	1,939 $624,000
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $49,397 - $60,030	-188 Reduced 5.84%	3,029 $946,000
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $10,485 - $12,657	-39 Reduced 1.2%	3,217 $914,000
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $40,400 - $45,576	158 Added 5.1%	3,256 $937,000
Q3 2023 Feb 16, 2024	SELL	$218.65 - $271.46 $31,048 - $38,547	-142 Reduced 4.36%	3,114 $836,000
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $2,623 - $3,257	12 Added 0.39%	3,098 $832,000
Q2 2023 Feb 16, 2024	SELL	$214.27 - $253.37 $36,425 - $43,072	-170 Reduced 5.22%	3,086 $685,000
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $4,499 - $5,320	21 Added 0.69%	3,086 $685,000
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $90,090 - $109,804	399 Added 14.97%	3,065 $740,000
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $6,412 - $8,148	28 Added 1.06%	2,666 $700,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $12,689 - $14,120	55 Added 2.13%	2,638 $642,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $31,136 - $34,444	142 Added 5.82%	2,583 $625,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $39,179 - $44,837	197 Added 8.78%	2,441 $549,000
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $43,090 - $50,486	203 Added 9.95%	2,244 $477,000
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $2,335 - $2,591	-10 Reduced 0.49%	2,041 $497,000
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 0.15%	2,051 $510,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $47,387 - $56,429	-219 Reduced 9.66%	2,048 $471,000
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $453,813 - $504,677	-1,934 Reduced 46.04%	2,267 $576,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $329,353 - $404,162	-1,665 Reduced 28.38%	4,201 $991,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $705,086 - $935,137	3,869 Added 193.74%	5,866 $1.19 Million
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $14,001 - $17,996	74 Added 3.85%	1,997 $481,000
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $8,879 - $10,639	-51 Reduced 2.58%	1,923 $372,000
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $329,065 - $385,739	1,974 New	1,974 $364,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $346,366 - $390,430	-1,915 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $60,834 - $71,013	341 Added 21.66%	1,915 $373,000
Q3 2018 Oct 15, 2018	BUY	$185.29 - $208.89 $11,117 - $12,533	60 Added 3.96%	1,574 $326,000
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $11,291 - $12,682	68 Added 4.7%	1,514 $279,000
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $36,596 - $42,768	-216 Reduced 13.0%	1,446 $247,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $280,528 - $313,436	1,662	1,662 $289,000

Others Institutions Holding AMGN

# of Institutions

3,282

Shares Held

441M

Call Options Held

6.14M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Investment Advisors LLC with notifications on news.

Account

Main Street Investment Advisors LLC Amgen Inc Transaction History